TrialClinical and translational science2022

A phase I randomized, double-blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects.

Kenan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.